REGULATORY

• Gilead Japan Expected to Offer Remdesivir for Free for Now
  May 7, 2020

• Japan to Test Ivermectin for COVID-19: Prime Minister
  May 7, 2020

• Japan Eyes May Approval for Avigan with Investigator-Led Study Data
  May 7, 2020

• Japan Eyes Manufacturing Repatriation for 3 APIs: Extra Budget
  May 1, 2020

• Japan Likely to Take FDA’s Anticipated EUA as Cue for “Special” Remdesivir OK
  May 1, 2020

• Japan Can’t Give “Special Approval” for Avigan under Current Law: Abe
  April 30, 2020

• Japan to Quickly Utilize “Special Approval” Scheme for Remdesivir after It’s OK’ed Overseas: Minister
  April 30, 2020

• Antigen Test for New Coronavirus Filed in Japan: Minister
  April 28, 2020

• Japan Might Approve Gilead’s Remdesivir for COVID-19 in May
  April 28, 2020

• Japan Starts Assessing Performance of Antibody Test Kits: Minister
  April 27, 2020

• Drug Makers Should Join in “Concerted National Effort” to Propel Regulatory Harmonization in Asia: Ex-PMDA Chair
  April 27, 2020

• Japan Moving to Thwart Foreign Takeover of Drug, Medical Devices Makers
  April 24, 2020

• In a First, Chuikyo to Be Streamed Live amid COVID-19 Outbreak
  April 23, 2020

• Japan to Make Drug Review Time as Short as Possible for COVID-19: Minister
  April 22, 2020

• Novartis’ Entresto, Mayzent Up for MHLW Panel Review in Round Robin Method
  April 20, 2020

• Japan Declares Nationwide State of Emergency
  April 17, 2020

• MSD’s 9-Valent HPV Vaccine Up for Review in 1st Online PAFSC Meeting
  April 16, 2020

• Novartis’ Flawed and Delayed Inquiry Responses in Zolgensma Review “Extremely Unusual”: PMDA Report
  April 16, 2020

• Osaka Pref., Osaka Univ. Form Alliance for COVID-19 Vaccine; AnGes Clinical Study Planned as Early as July
  April 16, 2020

• MHLW Asks Drug Makers, Wholesalers to Reduce People Coming to Work by “at Least 70%”
  April 15, 2020

ページ

• « 先頭
• ‹ Prev
• …
• 179
• 180
• 181
• 182
• 183
• 184
• 185
• 186
• 187
• …
• Next ›
• 最終 »